Glaucoma Treatment in Nursing Home Often Combined with Other Meds

Published Online: Tuesday, September 17, 2013
Follow Pharmacy_Times:
Nursing home residents with glaucoma often receive their treatment concurrently with other medications, which may compromise the efficacy and safety of the therapies, suggest the results of a study appearing in the January 2013 edition of Drugs & Aging.

Researchers received data for 8685 German nursing home residents with 88,695 prescriptions, and analyzed the information according to diagnosis and local or systemic pharmacotherapy. Participants (520) with glaucoma were identified, with 341 having prescriptions for glaucoma medications. The most frequently prescribed glaucoma therapies included ophthalmic beta-blockers, prostaglandin analogues, and carbonic anhydrase inhibitors.

All of the participants with glaucoma had coexisting medical conditions, and 337 participants received local glaucoma therapy in combination with systemic therapy for a comorbid condition. In 71.9% of patients, an ophthalmic beta-blocker was prescribed concomitantly with antihypertensive medications, and 20.2% of those cases involved a local and systemic beta-blocker. Treatment with cardiac glycosides or calcium antagonists occurred in 13% of patients receiving ophthalmic parasympathomimetics, and in 14% of patients receiving ophthalmic beta-blocker therapy, with a potential for brachycardia.

The researchers also noted the potential for glaucoma therapies to affect psychiatric or metabolic disease therapies.

Related Articles
Two groups of students from MCPHS University were named winners of the People’s Choice Poster Competition at the 10th Annual New England Pharmacists Convention.
Current risk assessment strategies for reducing fractures related to osteoporosis among women fail to accurately predict who will experience major osteoporotic injuries.
Adults aged 50 years or older who feel comfortable about aging are more likely to seek preventive health care services.
The vaccine that prevents illness and death from pneumococcal infection also combats severe antibiotic-resistant disease in young children.
Latest Issues
$auto_registration$